washington semaglutide & tirzepatide vs 2026: 22% vs 15% Weight Loss Guide Switching between weight-loss medications -

3 , e85 (2007)

Retatrutide is an investigational triple receptor agonist currently being evaluated in clinical research for its interaction with: GLP-1 (Glucagon-Like Peptide-1) receptors GIP (Glucose-Dependent Insulinotropic Polypeptide) receptors Glucagon receptors Its triple-receptor mechanism has made it an active area of investigation in metabolic physiology and endocrine signalling research

Front Endocrinol (Lausanne) 16:1520835 Jomova K, Raptova R, Alomar SY, Alwasel SH, Nepovimova E, Kuca K et al (2023) Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging

Has a fiduciary duty to act in the best interests of participants